Suez Canal Blockage Will Have Unexpected Consequences

In a race against time, the cargo ship crisis that almost became a major global disaster, ended in victory this week. The Ever Given, the cargo ship at the center of this dilemma, was stuck at a crucial place in the Suez Canal that resulted in hundreds of ships unable to deliver their goods to Europe and Asia. But this victory still comes at a price; shipping analysts are projecting the traffic jam was holding up close to 10 billion in trade every day. Transporeon’s CEO Stephan Sieber spoke to Bloomberg about why this has been critical and what to expect now that the ship has been freed.

 

 

Sieber says, “I mean, it all goes back to the pandemic, which in essence means that many services have been cut down or less traveled is less gastronomy. People are not leaving homes anymore. And as a consequence, the consumption of goods at home is just increasing. And this leads to an increase in demand, mainly from goods from China and that sort of the whole situation out of its equilibrium, equilibrium. And I think as we approach summer. And as hopefully, you know, the pandemic will slowly but surely come to an end, you know, we do expect that a few months afterwards, the whole system will relax again.”

The shutdown has been affecting close to 15 percent of the world’s container shipping capacity according to Moody’s Investor Service, meaning more delays at ports around the world. Thankfully, so far, the impact has been small despite the major interruption, which can only be described as a terrible “oar-deal”.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More